Injectable antispasmodic medications for cerebral palsy

References

Citations

1. Ade-Hall RA, Moore AP (2006). Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

2. Koman LA, et al. (2001). Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: A multicenter, open-label clinical trial. Pediatrics, 108(5): 1062–1071.

3. Koman LA, et al. (2004). Cerebral palsy. Lancet, 363(9421): 1619–1631.

Author:	Douglas Dana Sabra L. Katz-Wise Ralph Poore	Last Updated: March 6, 2007
Medical Review:	Anne C. Poinier, MD - Internal Medicine Michael J. Sexton, MD - Pediatrics Thomas Emmett Francoeur, MDCM, CSPQ, FRCPC - Pediatrics Louis Pellegrino, MD - Developmental Pediatrics
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.